A-prf,Nanochitosan Combined With A-prf Compared to Chitosan for Symptomatic Irreversible Pulpitis of Mature Teeth
1 other identifier
interventional
30
1 country
1
Brief Summary
Clinical and radiographic assessment of A-prf,A-prf combined with nanochitosan compared to chitosan for symptomatic irreversible pulpits in lower permanent first molar
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 2, 2023
CompletedFirst Submitted
Initial submission to the registry
May 15, 2024
CompletedFirst Posted
Study publicly available on registry
June 3, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
May 2, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
September 2, 2025
CompletedJune 3, 2024
May 1, 2024
1.7 years
May 15, 2024
May 30, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
pain assessment
Pain assessment using numerical rate scale
6,12,24,72hours and 7 days postoperative
Secondary Outcomes (1)
Clinical and radiographic success
1,3,6,9and 12 months
Study Arms (3)
Advanced Platelet rich fibrin,A-prf,A-PRF scaffold
EXPERIMENTALA-PRF will be prepared according to Choukroun's technique by drawing whole blood from the median cubital vein into a 10 ml plain plastic test tubes (non-citrated) without the addition of an anticoagulant reagent . To prevent the blood from coagulating, it will be centrifuged immediately using a table top centrifuge at 1500 rpm for 14 minute.
A-prf mixed with nano chitosan
EXPERIMENTALA-PRF will be prepared according to Choukroun's technique by drawing whole blood from the median cubital vein into a 10 ml plain plastic test tubes (non-citrated) without the addition of an anticoagulant reagent . To prevent the blood from coagulating, it will be centrifuged immediately using a table top centrifuge at 1500 rpm for 14 minute then mixed with nanochitosan
chitosan
EXPERIMENTALhe access cavity will be prepared up to the level of pulp chamber floor using sterile round diamond bur size 1 in high-speed hand piece with coolant.Once the pulp has been reached, a sharp sterile excavator should be used to remove the pulp tissue to the level of the radicular/root canal orifices then chitosan will be applied
Interventions
Removal of coronal pulp and expose the orifices to apply the materials with aim to preserve vitality of remaining pulp
Eligibility Criteria
You may qualify if:
- Patients suffering from Symptomatic irreversible pulpitis in mature mandibular molars only will be involved.
- Patients of either gender aged from 15-30.
- Tooth should give positive response to cold test.
- Haemostasias should be achieved after total pulpotomy.
- The tooth is restorable and free from advanced periodontal disease, cracks and splits.
- Patients should be free from any systemic disease that may affect normal healing and predictable outcome.
- Patients who will agree to the consent and will commit to follow-up period.
- Patients with mature root.
- Patients with no internal or external resorption and no periapical lesions.
- Soft tissues around the tooth are normal with no swelling or sinus tract.
You may not qualify if:
- Patients with immature roots.
- Haemostasias after 10 minutes can not be controlled after total pulpotomy
- Patients with any systemic disease that may affect normal healing.
- Patients with periapical lesions or infections.
- Pregnant females.
- Patients who could/would not participate in a 6 months follow-up.
- Patients with fistula or swelling
- Patients with necrotic pulp.
- Patients with old age.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Future university
Cairo, Fifth Settlement, 11813, Egypt
Study Officials
- STUDY DIRECTOR
wael H Kamel, Prof.
Future University in Egypt
- PRINCIPAL INVESTIGATOR
Hani s sadek, Prof.
Future University in Egypt
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Researcher
Study Record Dates
First Submitted
May 15, 2024
First Posted
June 3, 2024
Study Start
September 2, 2023
Primary Completion
May 2, 2025
Study Completion
September 2, 2025
Last Updated
June 3, 2024
Record last verified: 2024-05
Data Sharing
- IPD Sharing
- Will not share